UnknownNot Applicable

To Study the Effect of Short-chain Fructooligosaccharides in Women With Irritable Bowel Syndrome

40 participantsStarted 2024-12-02

Plain-language summary

To evaluate whether there is clinical improvement through the scales (Bristol, IBS severity score, and IBS quality of life) in women with irritable bowel syndrome after administration of SC-FOS (short-chain fructooligosaccharides).

Who can participate

Age range18 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female sex * Age 18 to 65 years * Irritable Bowel Syndrome diagnosed by Rome Criterion * Useful enteral feeding Exclusion Criteria: * Recent gastrointestinal disease \< 2 weeks different to IBS * Previous consumption of SC-FOS * Pregnancy

What they're measuring

Score of IBS-QOL

Timeframe: 10 days

Score of Bristol Scale

Timeframe: 10 days

Score of IBS-SSS

Timeframe: 10 days

Trial details

NCT IDNCT05941650

SponsorUniversidad Autonoma de Chihuahua

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-10

Contact for this trial

Carolina Martinez Loya

+526143543923 caromtzloya@gmail.com

View on ClinicalTrials.gov More Irritable Bowel Syndrome trials